Ozempic, Wegovy (semaglutide) vs Mounjaro, Zepbound (tirzepatide)

Wegovy vs Zepbound

Background Wegovy and Zepbound are both approved for weight loss but started as medications for type 2 diabetes. Wegovy was originally approved under the name Ozempic in 2017, followed by Wegovy in 2021 for weight loss. Ozempic and Wegovy both contain the active ingredient semaglutide, a GLP-1 receptor agonist that helps with weight loss via […]

Oral semaglutide for weight loss

oral semaglutide

You’ve heard amazing testimonials online and on social media regarding weight loss on Ozempic, Wegovy and Mounjaro. These medications contain the active ingredient semaglutide in the case of Ozempic and Wegovy, or tirzepatide in the case of Mounjaro. These are weekly injections. As soon as some patients hear these are injections (albeit with small needles), […]

What labs do I need to order for patients joining my weight management program?

labs

None of the lab work that is recommended for patients before starting a weight management program (WMP) will preclude them from taking the medication. We’ll discuss why below. But it’s still helpful to have baseline bloodwork to determine if the patient has any underlying issues that they don’t know about, but should. If lab work […]

What are the options for sending weight loss meds to patients

bottle of compounded semaglutide

You’ve started a weight management program (WMP) in your practice, you’ve established a relationship with a compounding pharmacy that offers injectable semaglutide and tirzepatide and they’re licensed in your state. You even have patients that have completed their lab work and signed up for the medications. But how do get the meds to them? Here […]

How to set up a weight management program in 5 steps!

How to start a weight management program

Interested in offering the newest weight management medications to your existing and future patients? Medications like semaglutide (active ingredient in Ozempic and Wegovy) or tirzepatide (active ingredient in Mounjaro and Zepbound). This class of GLP-1 receptor agonists are currently the talk of the town, and for good reason. With weight loss of between 15-20%, without […]

Ozempic is safe. How fake news wants you to believe otherwise.

The medications you’ve been hearing so much about are just shy of miraculous. And that’s not hyperbole. These medications have all of the positives of effective weight loss meds (they help you lose weight!) without the worse possible side effects (heart valve dysfunction with Fen-Phen in the ’90’s or the side effects associated with amphetamines) […]

Much ado about nothing? Recent FDA alerts and NovoNordisk lawsuits

Instagram post of Wegovy and Mounjaro

Due to the blockbuster weight loss drugs Ozempic, Wegovy and Mounjaro going on the FDA Shortage List, compounding pharmacies are legally allowed to make duplicates of these name brand drugs without risk of patent infringement. And even though NovoNordisk, the maker of Ozempic and Wegovy, admits they can’t keep up with demand, they’re trying everything […]

Shame on you Mississippi and West Virginia

certificate of analysis

Why would Mississippi and West Virginia, states that are ranked #1 and #4 in poverty, #5 and #1 in adult obesity, and #2 and #4 in adolescent obesity, respectively, eliminate access to the most affordable version of the safe and effective weight loss drugs Ozempic and Wegovy?   Background on Ozempic and Wegovy Not since […]

Consumers’ misguided focus on the risks surrounding Ozempic and Wegovy

semaglutide bottle

Consumers reluctant to try new weight loss drugs seem to focus more on the least likely risks such as pancreatitis and a rare type of thyroid cancer rather than focusing on the more common side effects like burping, nausea, vomiting, constipation and diarrhea. Instead of focusing on the risks associated with taking the medication, patients […]

Join over 7,000+ providers receiving insights in their inbox to boost their revenue and help their patient satisfaction with our turn-key weight management program.

This field is for validation purposes and should be left unchanged.